Travere Therapeutics (TVTX) Current Leases (2020 - 2025)
Historic Current Leases for Travere Therapeutics (TVTX) over the last 6 years, with Q3 2025 value amounting to $5.7 million.
- Travere Therapeutics' Current Leases rose 825.0% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 825.0%. This contributed to the annual value of $5.4 million for FY2024, which is 1010.39% up from last year.
- According to the latest figures from Q3 2025, Travere Therapeutics' Current Leases is $5.7 million, which was up 825.0% from $5.6 million recorded in Q2 2025.
- Over the past 5 years, Travere Therapeutics' Current Leases peaked at $5.7 million during Q3 2025, and registered a low of $3.9 million during Q4 2021.
- Its 5-year average for Current Leases is $4.8 million, with a median of $4.8 million in 2023.
- As far as peak fluctuations go, Travere Therapeutics' Current Leases skyrocketed by 99467.79% in 2021, and later soared by 825.0% in 2025.
- Travere Therapeutics' Current Leases (Quarter) stood at $3.9 million in 2021, then rose by 13.43% to $4.4 million in 2022, then increased by 10.74% to $4.9 million in 2023, then grew by 10.1% to $5.4 million in 2024, then increased by 6.09% to $5.7 million in 2025.
- Its last three reported values are $5.7 million in Q3 2025, $5.6 million for Q2 2025, and $5.5 million during Q1 2025.